On The Road And Through The Window: Inside Three Biotech IPOs
This article was originally published in Start Up
Executive Summary
Ophthotech, OncoMed, and bluebird bio are three of the dozens of biotechs that have made public debuts this year. Here’s how they did it, and the decisions they made to take advantage of being in the right place at the right time.